SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

70 hedge funds and large institutions have $105M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
-5
Holders Change %
-6.67%
% of All Funds
1.02%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
12
Increased
19
Reduced
11
Closed
17
Calls
$144K
Puts
$17K
Net Calls
+$127K
Net Calls Change
-$32K
Name Holding Trade Value Shares
Change
Shares
Change %
YIH
76
Y-Intercept (HK)
Hong Kong
-$98.8K -18,463 Closed
BHCM
77
Brevan Howard Capital Management
Jersey
-$85.8K -16,036 Closed
CIBC Asset Management
78
CIBC Asset Management
Ontario, Canada
-$82.4K -15,398 Closed
Squarepoint
79
Squarepoint
New York
-$79.7K -14,890 Closed
American Century Companies
80
American Century Companies
Missouri
-$72.9K -13,624 Closed
VF
81
Virtu Financial
New York
-$64K -12,030 Closed
OAC
82
OMERS Administration Corp
Ontario, Canada
-$63.1K -11,800 Closed
Two Sigma Advisers
83
Two Sigma Advisers
New York
-$61.8K -11,550 Closed
XT
84
XTX Topco
Cayman Islands
-$58.6K -10,949 Closed
Macquarie Group
85
Macquarie Group
Australia
-$3 -613 Closed
IA
86
IFP Advisors
Florida
-$2.34K -438 Closed
Fidelity Investments
87
Fidelity Investments
Massachusetts
-$380 -71 Closed